To include your compound in the COVID-19 Resource Center, submit it here.

Modest first-day pop for Arcus after upsized $120M IPO

Arcus Biosciences Inc. (NYSE:RCUS) climbed $2.08 (14%) to $17.08 on Thursday after raising $120 million through the sale of 8 million shares at $15

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE